T. Rowe Price Associates’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$406K Buy
78,456
+5,677
+8% +$29.4K ﹤0.01% 2399
2025
Q1
$485K Buy
72,779
+5,924
+9% +$39.5K ﹤0.01% 2254
2024
Q4
$493K Buy
66,855
+9,009
+16% +$66.4K ﹤0.01% 2282
2024
Q3
$405K Buy
57,846
+8,015
+16% +$56.1K ﹤0.01% 2341
2024
Q2
$245K Buy
49,831
+7,465
+18% +$36.7K ﹤0.01% 2508
2024
Q1
$262K Buy
42,366
+4,681
+12% +$28.9K ﹤0.01% 2497
2023
Q4
$296K Buy
37,685
+1,933
+5% +$15.2K ﹤0.01% 2379
2023
Q3
$246K Buy
35,752
+2,455
+7% +$16.9K ﹤0.01% 2418
2023
Q2
$305K Buy
33,297
+19,674
+144% +$180K ﹤0.01% 2354
2023
Q1
$102K Buy
13,623
+1,294
+10% +$9.69K ﹤0.01% 2684
2022
Q4
$61K Buy
12,329
+1,127
+10% +$5.58K ﹤0.01% 2788
2022
Q3
$75K Buy
+11,202
New +$75K ﹤0.01% 2779
2021
Q3
Sell
-14,094
Closed -$393K 2962
2021
Q2
$393K Buy
+14,094
New +$393K ﹤0.01% 2480